TACI/TNFRSF13B/CVID Antibody (1A1) - BSA Free, Novus Biologicals™
Manufacturer: Novus Biologicals
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NB119766-Each-of-1 | In Stock | ₹ 36,445.50 |
NB119766 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 36,445.50
GST (18%): ₹ 6,560.19
Total Price: ₹ 43,005.69
Antigen
TACI/TNFRSF13B/CVID
Classification
Monoclonal
Concentration
1 mg/ml
Dilution
Flow Cytometry 1-4 ug/ml
Gene Alias
CD267, CD267 antigen, CVID, CVID2, FLJ39942, MGC133214, TACIMGC39952, TNFRSF14B, Transmembrane activator and CAML interactor, tumor necrosis factor receptor 13B, tumor necrosis factor receptor superfamily member 13B, tumor necrosis factor receptor superfamily, member 13B
Immunogen
TACI/TNFRSF13B/CVID-transfected RBL cells
Quantity
0.1 mg
Research Discipline
Apoptosis, B Cell Development and Differentiation Markers, Signal Transduction
Gene ID (Entrez)
23495
Content And Storage
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Isotype
IgG2a κ
Applications
Flow Cytometry
Clone
1A1
Conjugate
Unconjugated
Formulation
PBS
Host Species
Rat
Purification Method
Protein A purified
Regulatory Status
RUO
Primary or Secondary
Primary
Target Species
Human
Form
Purified
Related Products
Description
- TACI/TNFRSF13B/CVID Monoclonal specifically detects TACI/TNFRSF13B/CVID in Human samples
- It is validated for Flow Cytometry.